Latest Insider Transactions at Sanara Med Tech Inc. (SMTI)
This section provides a real-time view of insider transactions for Sanara Med Tech Inc. (SMTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sanara MedTech Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sanara MedTech Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Keith G Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,975
+50.0%
|
-
|
|
Jun 12
2024
|
Eric D Major Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,440
+36.02%
|
-
|
|
Jun 12
2024
|
Robert Andrew De Sutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,932
+16.81%
|
-
|
|
Jun 12
2024
|
Ronald T Nixon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,812
+16.06%
|
-
|
|
Jun 12
2024
|
Ann Beal Salamone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,949
+12.91%
|
-
|
|
Jun 12
2024
|
James W Stuckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,440
+0.41%
|
-
|
|
Jun 12
2024
|
Eric D Tanzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,768
+21.13%
|
-
|
|
Jun 12
2024
|
Roszell Mack Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+21.57%
|
-
|
|
Jun 12
2024
|
Sara N Ortwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,440
+16.41%
|
-
|
|
Apr 15
2024
|
Jacob A. Waldrop Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,101
+50.0%
|
-
|
|
Mar 07
2024
|
Michael D. Mc Neil Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,650
+15.17%
|
-
|
|
Mar 07
2024
|
Zachary B. Fleming Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,693
+20.62%
|
-
|
|
Mar 01
2024
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,716
-2.29%
|
$65,208
$38.96 P/Share
|
|
Mar 01
2024
|
Michael D. Mc Neil Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-2.88%
|
$48,868
$38.96 P/Share
|
|
Feb 01
2024
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.11%
|
$14,091
$33.72 P/Share
|
|
Feb 01
2024
|
Michael D. Mc Neil Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
391
-1.7%
|
$12,903
$33.72 P/Share
|
|
Jan 01
2024
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,255
-3.17%
|
$51,455
$41.1 P/Share
|
|
Sep 21
2023
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-1.7%
|
$25,308
$37.19 P/Share
|
|
Jun 01
2023
|
Roszell Mack Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,802
+22.78%
|
-
|
|
Jun 01
2023
|
Ann Beal Salamone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,402
+12.41%
|
-
|
|
Jun 01
2023
|
Ronald T Nixon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,417
+18.41%
|
-
|
|
Jun 01
2023
|
Eric D Major Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,669
+50.0%
|
-
|
|
Jun 01
2023
|
Sara N Ortwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,802
+16.6%
|
-
|
|
Jun 01
2023
|
Robert Andrew De Sutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,936
+15.91%
|
-
|
|
Jun 01
2023
|
James W Stuckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,802
+0.33%
|
-
|
|
Jun 01
2023
|
Eric D Tanzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,936
+22.18%
|
-
|
|
Apr 12
2023
|
Michael D. Mc Neil Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.16%
|
$6,000
$6.0 P/Share
|
|
Mar 17
2023
|
Michael D. Mc Neil Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,443
-2.09%
|
$59,163
$41.77 P/Share
|
|
Mar 17
2023
|
Rebecca E Mc Mahon President - R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-2.05%
|
$8,241
$41.5 P/Share
|
|
Mar 17
2023
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-1.75%
|
$121,155
$41.45 P/Share
|
|
Mar 02
2023
|
Rebecca E Mc Mahon President - R&D |
BUY
Grant, award, or other acquisition
|
Direct |
2,410
+19.74%
|
-
|
|
Mar 02
2023
|
Michael D. Mc Neil Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,217
+15.23%
|
-
|
|
Mar 02
2023
|
Zachary B. Fleming Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,724
+9.14%
|
-
|
|
Dec 02
2022
|
Michael D. Mc Neil Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,118
-2.77%
|
$29,068
$26.88 P/Share
|
|
Dec 02
2022
|
Shawn M. Bowman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,414
-27.79%
|
-
|
|
Dec 02
2022
|
Shawn M. Bowman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,667
-3.77%
|
$80,010
$30.35 P/Share
|
|
Dec 02
2022
|
Zachary B. Fleming Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,796
-2.49%
|
$46,696
$26.88 P/Share
|
|
Nov 08
2022
|
Zachary B. Fleming Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
417
-1.14%
|
$13,761
$33.0 P/Share
|
|
Nov 04
2022
|
Zachary B. Fleming Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
563
-1.51%
|
$18,579
$33.0 P/Share
|
|
Nov 02
2022
|
Zachary B. Fleming Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20
-0.05%
|
$660
$33.02 P/Share
|
|
Sep 22
2022
|
Shawn M. Bowman |
SELL
Open market or private sale
|
Direct |
1,000
-2.59%
|
$28,000
$28.05 P/Share
|
|
Jul 07
2022
|
Eric D Tanzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+40.57%
|
-
|
|
Jul 07
2022
|
Kenneth E Thorpe Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+22.88%
|
-
|
|
Jul 07
2022
|
Ann Beal Salamone Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,113
+22.05%
|
-
|
|
Jul 07
2022
|
James W Stuckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,799
+0.57%
|
-
|
|
Jul 07
2022
|
Ronald T Nixon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,113
+13.1%
|
-
|
|
Jul 07
2022
|
Roszell Mack Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,570
+40.57%
|
-
|
|
Jul 07
2022
|
Robert Andrew De Sutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,256
+29.46%
|
-
|
|
Jul 07
2022
|
Sara N Ortwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,799
+29.85%
|
-
|
|
Jul 06
2022
|
Zachary B. Fleming Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,415
-1.85%
|
$31,130
$22.5 P/Share
|